Spero Therapeutics, Inc.
SPRO
$0.7542
$0.01421.92%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -30.71% | -18.69% | -18.23% | -14.53% | -30.04% |
Total Receivables | 3.51% | 1,682.60% | 2,557.81% | 2,806.97% | 4,576.85% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -54.26% | -62.00% | -62.71% | 3.53% | 23.65% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -18.24% | 28.77% | 38.34% | 37.86% | 15.53% |
|
|||||
Total Current Assets | -18.24% | 28.77% | 38.34% | 37.86% | 15.53% |
Net Property, Plant & Equipment | -25.09% | -23.94% | -24.02% | -24.11% | -24.31% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -99.67% | -64.75% | 318.45% | 311.93% | 719.25% |
Total Assets | -39.39% | 26.20% | 51.57% | 49.01% | 46.14% |
|
|||||
Total Accounts Payable | 430.19% | 452.13% | 105.80% | 425.90% | 123.34% |
Total Accrued Expenses | 433.66% | 133.55% | 79.99% | -39.02% | -23.09% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.63% | 1.64% | 1.64% | 1.65% | 1.66% |
Total Finance Division Other Current Liabilities | 63.83% | 61.27% | 256.58% | 166.32% | 154.23% |
Total Other Current Liabilities | 63.83% | 61.27% | 256.58% | 166.32% | 154.23% |
Total Current Liabilities | 32.09% | 92.83% | 163.41% | 81.93% | 71.62% |
|
|||||
Total Current Liabilities | 32.09% | 92.83% | 163.41% | 81.93% | 71.62% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -33.31% | -30.02% | -27.25% | -24.89% | -22.84% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -62.93% | -25.78% | -8.18% | 30.34% | 55.05% |
Total Liabilities | -14.67% | 30.45% | 57.32% | 49.78% | 54.49% |
|
|||||
Common Stock & APIC | 1.57% | 1.67% | 1.67% | 1.63% | 1.66% |
Retained Earnings | -17.53% | 0.79% | 3.98% | 5.48% | 5.51% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -56.85% | 21.98% | 46.95% | 48.44% | 40.77% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -56.85% | 21.98% | 46.95% | 48.44% | 40.77% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -56.85% | 21.98% | 46.95% | 48.44% | 40.77% |
|